Latest Administration News

Page 23 of 184
Nexsen Limited is advancing its rapid Group B Streptococcus test, StrepSure®, with a clear FDA submission timeline and early market entries across Asia-Pacific and emerging regions.
Ada Torres
Ada Torres
26 Mar 2026
Atomo Diagnostics has responded to an ASX price query following unusual trading activity, denying any undisclosed price-sensitive information while acknowledging a related FDA update involving Lumos Diagnostics.
Ada Torres
Ada Torres
25 Mar 2026
FINEOS Corporation reports robust FY25 financial performance, driven by subscription revenue growth and embedded AI innovations, setting a confident outlook through FY27.
Sophie Babbage
Sophie Babbage
25 Mar 2026
Recce Pharmaceuticals has expanded its intellectual property footprint with a newly granted patent in Brazil, protecting its innovative synthetic anti-infectives against a broad range of infections. This milestone strengthens Recce’s position in one of South America’s largest antibiotic markets.
Ada Torres
Ada Torres
24 Mar 2026
Coles Group Limited has updated its dividend details, confirming a fully franked 41 cent per share payout for the half-year ending January 2026, alongside a Dividend Reinvestment Plan price set at $21.32.
Logan Eniac
Logan Eniac
24 Mar 2026
Radiopharm Theranostics reports promising second interim Phase 2b results for RAD 101, showing 90% concordance with MRI in detecting brain metastases and encouraging sensitivity and specificity trends.
Ada Torres
Ada Torres
24 Mar 2026
Echo IQ has strengthened its partnership with Mayo Clinic to distribute its AI-driven heart failure diagnostic tool, EchoSolv HF, pending FDA clearance. The expanded agreement offers a scalable commercial pathway across a vast US hospital network.
Ada Torres
Ada Torres
24 Mar 2026
SQX Resources has addressed an ASX compliance query regarding director Bevan Tarratt’s trading during a closed period, confirming prior board approval and an administrative disclosure error.
Maxwell Dee
Maxwell Dee
23 Mar 2026
Generation Development Group Limited updates its Dividend Reinvestment Plan price to AUD 3.86 per share for the upcoming fully franked dividend, signalling steady shareholder returns for the half-year ending December 2025.
Claire Turing
Claire Turing
23 Mar 2026
Sequoia Financial Group has agreed to sell its financial planning arm InterPrac to Conquest Investment Partners for $50,000, following a strategic review that exposed significant challenges and asset write-downs.
Claire Turing
Claire Turing
23 Mar 2026
Nexsen Limited has successfully completed a pivotal FDA Pre-Submission meeting for its StrepSure® diagnostic, significantly reducing regulatory risks and advancing its entry into the large US maternal health market.
Ada Torres
Ada Torres
23 Mar 2026
Lindian Resources has operationalised its Tipume Accommodation Camp at the Kangankunde Rare Earths Project, enabling workforce expansion and accelerating construction towards first production in late 2026.
Maxwell Dee
Maxwell Dee
23 Mar 2026